CMS severely limits coverage of Alzheimer’s treatment: What it means for people living with the disease
CMS severely limits coverage of Alzheimer’s treatment: What it means for people living with the disease
WFMY News 2 | Jan 24, 2022
Recent Posts
- Medicare Limits Coverage of Controversial Alzheimer’s Drug to Those in Clinical Trials
- For People With Down Syndrome, A Longer Life, But Under A Cloud
- More Lawmakers Ratchet Up Pressure on CMS to Overturn Aduhelm Coverage Proposal
- National Coverage Determination May Limit Access to AD Treatment
- Medicare Proposal on Alzheimer’s Drug Draws Criticism From Drugmakers